Trials / Sponsors / Eleos, Inc.
Eleos, Inc.
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | A Study of Aezea® (Cenersen) in Transfusion Dependent Anemia Associated With Myelodysplastic Syndrome (MDS) Myelodysplastic Syndromes | Phase 1 | 2014-09-01 |
| Withdrawn | Aezea® (Cenersen) and Chemotherapy for AML Subjects ≥ 55 Years of Age With No Response to Frontline Induction Acute Myelogenous Leukemia | Phase 2 | 2012-01-01 |
| Completed | Dosing Study of Ara-C/EL625/Idarubicin in Refractory and Relapsed AML Acute Myelogenous Leukemia | Phase 2 | 2004-04-01 |